Quick Answer
NEOGENOMICS INC reported Cash And Cash Equivalents At Carrying Value of $159.62 million for the year ending 2025.
- NEOGENOMICS INC showed a decrease of -56.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from NEOGENOMICS INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), NEOGENOMICS INC's Cash And Cash Equivalents At Carrying Value has grown by 9,686.5%.
- Historical annual values: Fiscal year 2025: $159.62 million | Fiscal year 2024: $367.01 million | Fiscal year 2023: $342.49 million | Fiscal year 2022: $263.18 million | Fiscal year 2021: $316.83 million | Fiscal year 2020: $228.71 million | Fiscal year 2019: $173.02 million | Fiscal year 2018: $9.81 million | Fiscal year 2017: $12.82 million | Fiscal year 2016: $12.53 million | Fiscal year 2015: $23.42 million | Fiscal year 2014: $33.69 million | Fiscal year 2013: $4.83 million | Fiscal year 2012: $1.87 million | Fiscal year 2011: $2.63 million | Fiscal year 2010: $1.10 million | Fiscal year 2009: $1.63 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: